Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2026)
Treace Medical Concepts (TMCI) posted Amortization of Deferred Charges of $262000.0 for Q1 2026, up 279.71% on a QoQ basis from $69000.0 in Q4 2025, and up 254.05% year-over-year from $74000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $262000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 254.05% year-over-year to $262000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480000.0 (up 61.62% YoY) and the FY2025 annual result came in at $292000.0, down 2.01% from the prior year.
- Amortization of Deferred Charges was $262000.0 for Q1 2026 at Treace Medical Concepts, up from $69000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $262000.0 in Q1 2026 and bottomed at $45000.0 in Q1 2022.
- A 5-year average of $81941.2 and a median of $74000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2025 — Amortization of Deferred Charges decreased 8.0% — and 2026, when it surged 254.05%.
- Treace Medical Concepts' Amortization of Deferred Charges stood at $75000.0 in 2022, then fell by 1.33% to $74000.0 in 2023, then gained by 1.35% to $75000.0 in 2024, then declined by 8.0% to $69000.0 in 2025, then surged by 279.71% to $262000.0 in 2026.
- Business Quant data shows TMCI's Amortization of Deferred Charges at $262000.0 in Q1 2026, $69000.0 in Q4 2025, and $75000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 74,000.00 |
| Sep 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Dec 31, 2023 | 74,000.00 |